Perrigo completes divestiture of Generic Rx Pharmaceuticals
Perrigo Company plc completed the sale of its generic drug business to a New York-based private equity firm for $1.55 billion.
Perrigo completes divestiture of Generic Rx Pharmaceuticals
Perrigo Company plc completed the sale of its generic drug business to a New York-based private equity firm for $1.55 billion.